Endovascular stenting for chronic femoro-iliac venous obstructive disease: Clinical efficacy and short-term outcomes
To report the clinical efficacy and mid-term outcomes of endovascular treatment in patients with chronic, symptomatic, post-thrombotic femoro-iliac venous obstruction. Forty-two patients with post-thrombotic syndrome (PTS) presenting with femoro-iliac venous obstructive lesions treated in our instit...
Gespeichert in:
| Veröffentlicht in: | Diagnostic and interventional imaging 2020-01, Vol.101 (1), p.15-23 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 23 |
|---|---|
| container_issue | 1 |
| container_start_page | 15 |
| container_title | Diagnostic and interventional imaging |
| container_volume | 101 |
| creator | Guillen, K. Falvo, N. Nakai, M. Chevallier, O. Aho-Glélé, S. Galland, C. Demaistre, E. Pescatori, L. Samson, M. Audia, S. Bonnotte, B. Midulla, M. Loffroy, R. |
| description | To report the clinical efficacy and mid-term outcomes of endovascular treatment in patients with chronic, symptomatic, post-thrombotic femoro-iliac venous obstruction.
Forty-two patients with post-thrombotic syndrome (PTS) presenting with femoro-iliac venous obstructive lesions treated in our institution by endovascular approach between March 2012 and October 2017 were retrospectively included. There were 27 women and 15 men with a mean age of 47.3±17 (SD) years (range: 22–86 years). Procedure included first venous recanalization, then pre-dilatation and self-expandable metallic stenting of the narrowed or occluded iliac and/or femoral veins. Severity of PTS and quality of life were assessed at baseline and 3 months after the intervention respectively, using Villalta score and Chronic Venous Insufficiency Questionnaire (CIVIQ-20) scale. Imaging follow-up evaluation of stent patency was based on the results of duplex Doppler ultrasound and computed tomography.
Immediate technical success was achieved in 41/42 (97.6%) patients, without any major complications. Primary patency, primary assisted patency and secondary patency at the end of the median imaging follow-up of 18.1 months (IQR, 9.7–34.4) were achieved in 29/42 (66.7%) patients, 33/42 (78.6%) patients and 37/42 (88.1%) patients, respectively. Median Villalta and CIVIQ-20 scores decreased from 14 (IQR, 10–19) and 57 (IQR, 39–72) at baseline, respectively, to 5 (IQR, 2–9) and 30 (IQR, 24–50) 3 months after the procedure, respectively (P |
| doi_str_mv | 10.1016/j.diii.2019.03.014 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_03125112v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2211568419300877</els_id><sourcerecordid>2217479083</sourcerecordid><originalsourceid>FETCH-LOGICAL-c434t-7a998b7870246d8b31b047b77f6a0227ae60423eac301ad4aab331c13cd8e2023</originalsourceid><addsrcrecordid>eNp9kU1r3DAQhkVpaUKaP9BD0LE92NXXWt6SS1jyUVjopT2LsTTuarGtRJIN---jZZOQU-cyg3jed9C8hHzlrOaMNz_2tfPe14Lxdc1kzbj6QM6F4LxaNa36-G4-I5cp7VmppgiV-kzOJGeyWcnVOcm3kwsLJDsPEGnKOGU__aN9iNTuYpi8pT2OIYbKDx4sXXAKc6KhSznONvsFqfMJIeFPuhl84WGg2Pel2wOFydG0CzFXGeNIw5xtGDF9IZ96GBJevvQL8vfu9s_modr-vv-1udlWVkmVKw3rddvpVjOhGtd2kndM6U7rvgEmhAZsmBISwUrGwSmATkpuubSuRcGEvCDfT747GMxj9CPEgwngzcPN1hzfmORixblYeGG_ndjHGJ5mTNmMPlkcBpiw_NiUc2ql16yVBRUn1MaQUsT-zZszcwzH7M0xHHMMp-wwJZwiunrxn7sR3ZvkNYoCXJ8ALBdZPEaTrMfJovMRbTYu-P_5PwNm2aB5</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2217479083</pqid></control><display><type>article</type><title>Endovascular stenting for chronic femoro-iliac venous obstructive disease: Clinical efficacy and short-term outcomes</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Guillen, K. ; Falvo, N. ; Nakai, M. ; Chevallier, O. ; Aho-Glélé, S. ; Galland, C. ; Demaistre, E. ; Pescatori, L. ; Samson, M. ; Audia, S. ; Bonnotte, B. ; Midulla, M. ; Loffroy, R.</creator><creatorcontrib>Guillen, K. ; Falvo, N. ; Nakai, M. ; Chevallier, O. ; Aho-Glélé, S. ; Galland, C. ; Demaistre, E. ; Pescatori, L. ; Samson, M. ; Audia, S. ; Bonnotte, B. ; Midulla, M. ; Loffroy, R.</creatorcontrib><description>To report the clinical efficacy and mid-term outcomes of endovascular treatment in patients with chronic, symptomatic, post-thrombotic femoro-iliac venous obstruction.
Forty-two patients with post-thrombotic syndrome (PTS) presenting with femoro-iliac venous obstructive lesions treated in our institution by endovascular approach between March 2012 and October 2017 were retrospectively included. There were 27 women and 15 men with a mean age of 47.3±17 (SD) years (range: 22–86 years). Procedure included first venous recanalization, then pre-dilatation and self-expandable metallic stenting of the narrowed or occluded iliac and/or femoral veins. Severity of PTS and quality of life were assessed at baseline and 3 months after the intervention respectively, using Villalta score and Chronic Venous Insufficiency Questionnaire (CIVIQ-20) scale. Imaging follow-up evaluation of stent patency was based on the results of duplex Doppler ultrasound and computed tomography.
Immediate technical success was achieved in 41/42 (97.6%) patients, without any major complications. Primary patency, primary assisted patency and secondary patency at the end of the median imaging follow-up of 18.1 months (IQR, 9.7–34.4) were achieved in 29/42 (66.7%) patients, 33/42 (78.6%) patients and 37/42 (88.1%) patients, respectively. Median Villalta and CIVIQ-20 scores decreased from 14 (IQR, 10–19) and 57 (IQR, 39–72) at baseline, respectively, to 5 (IQR, 2–9) and 30 (IQR, 24–50) 3 months after the procedure, respectively (P<0.0001), showing significant decrease in the severity of PTS and improvement in the quality of life. The multiple linear regression model showed that both baseline Villalta and CIVIQ-20 scores ([95% CI: −7.80–3.79; P<0.0001] and [95% CI: 0.07–0.20; P<0.0001], respectively), age (95% CI: 0.04–0.19; P=0.002) and stenting expanse (95% CI: 0.97–5.65; P=0.006) were independent variables related to Villalta gain. Baseline Villalta (95% CI: 0.89–2.23; P<0.0001) was the single independent variable related to CIVIQ-20 gain.
This study confirms the high clinical efficacy and favorable mid-term outcomes of endovascular stenting in patients with chronic symptomatic femoro-iliac venous obstructive lesions.</description><identifier>ISSN: 2211-5684</identifier><identifier>EISSN: 2211-5684</identifier><identifier>DOI: 10.1016/j.diii.2019.03.014</identifier><identifier>PMID: 31036535</identifier><language>eng</language><publisher>France: Elsevier Masson SAS</publisher><subject>Endovascular treatment ; Iliac vein ; Life Sciences ; Post-thrombotic syndrome ; Quality of life ; Self expandable metallic stents</subject><ispartof>Diagnostic and interventional imaging, 2020-01, Vol.101 (1), p.15-23</ispartof><rights>2019 Société française de radiologie</rights><rights>Copyright © 2019 Société française de radiologie. Published by Elsevier Masson SAS. All rights reserved.</rights><rights>Attribution - NonCommercial</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c434t-7a998b7870246d8b31b047b77f6a0227ae60423eac301ad4aab331c13cd8e2023</citedby><cites>FETCH-LOGICAL-c434t-7a998b7870246d8b31b047b77f6a0227ae60423eac301ad4aab331c13cd8e2023</cites><orcidid>0000-0002-3107-5967 ; 0000-0001-7229-3808 ; 0000-0002-1098-4598</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27915,27916</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31036535$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-03125112$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Guillen, K.</creatorcontrib><creatorcontrib>Falvo, N.</creatorcontrib><creatorcontrib>Nakai, M.</creatorcontrib><creatorcontrib>Chevallier, O.</creatorcontrib><creatorcontrib>Aho-Glélé, S.</creatorcontrib><creatorcontrib>Galland, C.</creatorcontrib><creatorcontrib>Demaistre, E.</creatorcontrib><creatorcontrib>Pescatori, L.</creatorcontrib><creatorcontrib>Samson, M.</creatorcontrib><creatorcontrib>Audia, S.</creatorcontrib><creatorcontrib>Bonnotte, B.</creatorcontrib><creatorcontrib>Midulla, M.</creatorcontrib><creatorcontrib>Loffroy, R.</creatorcontrib><title>Endovascular stenting for chronic femoro-iliac venous obstructive disease: Clinical efficacy and short-term outcomes</title><title>Diagnostic and interventional imaging</title><addtitle>Diagn Interv Imaging</addtitle><description>To report the clinical efficacy and mid-term outcomes of endovascular treatment in patients with chronic, symptomatic, post-thrombotic femoro-iliac venous obstruction.
Forty-two patients with post-thrombotic syndrome (PTS) presenting with femoro-iliac venous obstructive lesions treated in our institution by endovascular approach between March 2012 and October 2017 were retrospectively included. There were 27 women and 15 men with a mean age of 47.3±17 (SD) years (range: 22–86 years). Procedure included first venous recanalization, then pre-dilatation and self-expandable metallic stenting of the narrowed or occluded iliac and/or femoral veins. Severity of PTS and quality of life were assessed at baseline and 3 months after the intervention respectively, using Villalta score and Chronic Venous Insufficiency Questionnaire (CIVIQ-20) scale. Imaging follow-up evaluation of stent patency was based on the results of duplex Doppler ultrasound and computed tomography.
Immediate technical success was achieved in 41/42 (97.6%) patients, without any major complications. Primary patency, primary assisted patency and secondary patency at the end of the median imaging follow-up of 18.1 months (IQR, 9.7–34.4) were achieved in 29/42 (66.7%) patients, 33/42 (78.6%) patients and 37/42 (88.1%) patients, respectively. Median Villalta and CIVIQ-20 scores decreased from 14 (IQR, 10–19) and 57 (IQR, 39–72) at baseline, respectively, to 5 (IQR, 2–9) and 30 (IQR, 24–50) 3 months after the procedure, respectively (P<0.0001), showing significant decrease in the severity of PTS and improvement in the quality of life. The multiple linear regression model showed that both baseline Villalta and CIVIQ-20 scores ([95% CI: −7.80–3.79; P<0.0001] and [95% CI: 0.07–0.20; P<0.0001], respectively), age (95% CI: 0.04–0.19; P=0.002) and stenting expanse (95% CI: 0.97–5.65; P=0.006) were independent variables related to Villalta gain. Baseline Villalta (95% CI: 0.89–2.23; P<0.0001) was the single independent variable related to CIVIQ-20 gain.
This study confirms the high clinical efficacy and favorable mid-term outcomes of endovascular stenting in patients with chronic symptomatic femoro-iliac venous obstructive lesions.</description><subject>Endovascular treatment</subject><subject>Iliac vein</subject><subject>Life Sciences</subject><subject>Post-thrombotic syndrome</subject><subject>Quality of life</subject><subject>Self expandable metallic stents</subject><issn>2211-5684</issn><issn>2211-5684</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kU1r3DAQhkVpaUKaP9BD0LE92NXXWt6SS1jyUVjopT2LsTTuarGtRJIN---jZZOQU-cyg3jed9C8hHzlrOaMNz_2tfPe14Lxdc1kzbj6QM6F4LxaNa36-G4-I5cp7VmppgiV-kzOJGeyWcnVOcm3kwsLJDsPEGnKOGU__aN9iNTuYpi8pT2OIYbKDx4sXXAKc6KhSznONvsFqfMJIeFPuhl84WGg2Pel2wOFydG0CzFXGeNIw5xtGDF9IZ96GBJevvQL8vfu9s_modr-vv-1udlWVkmVKw3rddvpVjOhGtd2kndM6U7rvgEmhAZsmBISwUrGwSmATkpuubSuRcGEvCDfT747GMxj9CPEgwngzcPN1hzfmORixblYeGG_ndjHGJ5mTNmMPlkcBpiw_NiUc2ql16yVBRUn1MaQUsT-zZszcwzH7M0xHHMMp-wwJZwiunrxn7sR3ZvkNYoCXJ8ALBdZPEaTrMfJovMRbTYu-P_5PwNm2aB5</recordid><startdate>202001</startdate><enddate>202001</enddate><creator>Guillen, K.</creator><creator>Falvo, N.</creator><creator>Nakai, M.</creator><creator>Chevallier, O.</creator><creator>Aho-Glélé, S.</creator><creator>Galland, C.</creator><creator>Demaistre, E.</creator><creator>Pescatori, L.</creator><creator>Samson, M.</creator><creator>Audia, S.</creator><creator>Bonnotte, B.</creator><creator>Midulla, M.</creator><creator>Loffroy, R.</creator><general>Elsevier Masson SAS</general><general>Elsevier</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><orcidid>https://orcid.org/0000-0002-3107-5967</orcidid><orcidid>https://orcid.org/0000-0001-7229-3808</orcidid><orcidid>https://orcid.org/0000-0002-1098-4598</orcidid></search><sort><creationdate>202001</creationdate><title>Endovascular stenting for chronic femoro-iliac venous obstructive disease: Clinical efficacy and short-term outcomes</title><author>Guillen, K. ; Falvo, N. ; Nakai, M. ; Chevallier, O. ; Aho-Glélé, S. ; Galland, C. ; Demaistre, E. ; Pescatori, L. ; Samson, M. ; Audia, S. ; Bonnotte, B. ; Midulla, M. ; Loffroy, R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c434t-7a998b7870246d8b31b047b77f6a0227ae60423eac301ad4aab331c13cd8e2023</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Endovascular treatment</topic><topic>Iliac vein</topic><topic>Life Sciences</topic><topic>Post-thrombotic syndrome</topic><topic>Quality of life</topic><topic>Self expandable metallic stents</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Guillen, K.</creatorcontrib><creatorcontrib>Falvo, N.</creatorcontrib><creatorcontrib>Nakai, M.</creatorcontrib><creatorcontrib>Chevallier, O.</creatorcontrib><creatorcontrib>Aho-Glélé, S.</creatorcontrib><creatorcontrib>Galland, C.</creatorcontrib><creatorcontrib>Demaistre, E.</creatorcontrib><creatorcontrib>Pescatori, L.</creatorcontrib><creatorcontrib>Samson, M.</creatorcontrib><creatorcontrib>Audia, S.</creatorcontrib><creatorcontrib>Bonnotte, B.</creatorcontrib><creatorcontrib>Midulla, M.</creatorcontrib><creatorcontrib>Loffroy, R.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><jtitle>Diagnostic and interventional imaging</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Guillen, K.</au><au>Falvo, N.</au><au>Nakai, M.</au><au>Chevallier, O.</au><au>Aho-Glélé, S.</au><au>Galland, C.</au><au>Demaistre, E.</au><au>Pescatori, L.</au><au>Samson, M.</au><au>Audia, S.</au><au>Bonnotte, B.</au><au>Midulla, M.</au><au>Loffroy, R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Endovascular stenting for chronic femoro-iliac venous obstructive disease: Clinical efficacy and short-term outcomes</atitle><jtitle>Diagnostic and interventional imaging</jtitle><addtitle>Diagn Interv Imaging</addtitle><date>2020-01</date><risdate>2020</risdate><volume>101</volume><issue>1</issue><spage>15</spage><epage>23</epage><pages>15-23</pages><issn>2211-5684</issn><eissn>2211-5684</eissn><abstract>To report the clinical efficacy and mid-term outcomes of endovascular treatment in patients with chronic, symptomatic, post-thrombotic femoro-iliac venous obstruction.
Forty-two patients with post-thrombotic syndrome (PTS) presenting with femoro-iliac venous obstructive lesions treated in our institution by endovascular approach between March 2012 and October 2017 were retrospectively included. There were 27 women and 15 men with a mean age of 47.3±17 (SD) years (range: 22–86 years). Procedure included first venous recanalization, then pre-dilatation and self-expandable metallic stenting of the narrowed or occluded iliac and/or femoral veins. Severity of PTS and quality of life were assessed at baseline and 3 months after the intervention respectively, using Villalta score and Chronic Venous Insufficiency Questionnaire (CIVIQ-20) scale. Imaging follow-up evaluation of stent patency was based on the results of duplex Doppler ultrasound and computed tomography.
Immediate technical success was achieved in 41/42 (97.6%) patients, without any major complications. Primary patency, primary assisted patency and secondary patency at the end of the median imaging follow-up of 18.1 months (IQR, 9.7–34.4) were achieved in 29/42 (66.7%) patients, 33/42 (78.6%) patients and 37/42 (88.1%) patients, respectively. Median Villalta and CIVIQ-20 scores decreased from 14 (IQR, 10–19) and 57 (IQR, 39–72) at baseline, respectively, to 5 (IQR, 2–9) and 30 (IQR, 24–50) 3 months after the procedure, respectively (P<0.0001), showing significant decrease in the severity of PTS and improvement in the quality of life. The multiple linear regression model showed that both baseline Villalta and CIVIQ-20 scores ([95% CI: −7.80–3.79; P<0.0001] and [95% CI: 0.07–0.20; P<0.0001], respectively), age (95% CI: 0.04–0.19; P=0.002) and stenting expanse (95% CI: 0.97–5.65; P=0.006) were independent variables related to Villalta gain. Baseline Villalta (95% CI: 0.89–2.23; P<0.0001) was the single independent variable related to CIVIQ-20 gain.
This study confirms the high clinical efficacy and favorable mid-term outcomes of endovascular stenting in patients with chronic symptomatic femoro-iliac venous obstructive lesions.</abstract><cop>France</cop><pub>Elsevier Masson SAS</pub><pmid>31036535</pmid><doi>10.1016/j.diii.2019.03.014</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-3107-5967</orcidid><orcidid>https://orcid.org/0000-0001-7229-3808</orcidid><orcidid>https://orcid.org/0000-0002-1098-4598</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2211-5684 |
| ispartof | Diagnostic and interventional imaging, 2020-01, Vol.101 (1), p.15-23 |
| issn | 2211-5684 2211-5684 |
| language | eng |
| recordid | cdi_hal_primary_oai_HAL_hal_03125112v1 |
| source | EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| subjects | Endovascular treatment Iliac vein Life Sciences Post-thrombotic syndrome Quality of life Self expandable metallic stents |
| title | Endovascular stenting for chronic femoro-iliac venous obstructive disease: Clinical efficacy and short-term outcomes |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T23%3A48%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Endovascular%20stenting%20for%20chronic%20femoro-iliac%20venous%20obstructive%20disease:%20Clinical%20efficacy%20and%20short-term%20outcomes&rft.jtitle=Diagnostic%20and%20interventional%20imaging&rft.au=Guillen,%20K.&rft.date=2020-01&rft.volume=101&rft.issue=1&rft.spage=15&rft.epage=23&rft.pages=15-23&rft.issn=2211-5684&rft.eissn=2211-5684&rft_id=info:doi/10.1016/j.diii.2019.03.014&rft_dat=%3Cproquest_hal_p%3E2217479083%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2217479083&rft_id=info:pmid/31036535&rft_els_id=S2211568419300877&rfr_iscdi=true |